Giant Biogene (02367) Proposes Final Dividend of RMB0.539 per Share for FY-2025

Bulletin Express03-19

Giant Biogene Holding Co., Ltd. (stock code: 02367) has declared a final ordinary dividend of RMB0.539 per share for the financial year ended 31 December 2025, according to its latest announcement released on 19 March 2026.

Shareholders will vote on the proposed payout at the annual general meeting scheduled for 28 May 2026. Key timetable details are as follows:

• Ex-dividend date: 01 June 2026 • Last day to lodge share transfers: 02 June 2026 (by 16:30) • Book-closure period: 03 to 08 June 2026 • Record date: 08 June 2026 • Payment date: 25 June 2026

The dividend will be denominated in Renminbi, with the Hong Kong dollar equivalent and the applicable exchange rate to be announced later. Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, will act as the share registrar.

The announcement did not specify any withholding-tax arrangements or outstanding warrants/convertible securities relevant to the distribution. As of the announcement date, the board comprises five executive directors—Mr. Yan Jianya, Ms. Ye Juan, Ms. Fang Juan, Ms. Zhang Huijuan and Ms. Yan Yubo—and three independent non-executive directors—Mr. Huang Jin, Mr. Shan Wenhua and Ms. Wong Sze Wing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment